| Value | Category | Cases | |
|---|---|---|---|
| 1 | Oral administration | 38 |
46.9%
|
| 2 | Intravenous injection | 1 |
1.2%
|
| 3 | Topical Application | 0 |
0%
|
| 4 | Intramuscular injection | 42 |
51.9%
|
| 5 | Per Vagina | 0 |
0%
|
| Sysmiss | 5915 |